Evaluation of Serum Albumin Level in Patients with Acute Coronary Syndrome
IFR Journal of Medical Science and Case Report · 20.05.2025 · 1 (2) · 7-11
DOI: 10.70146/mscrv01i02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift IFR Journal of Medical Science and Case Report, erschienen am 20.05.2025. Verfasst von Yildiz Hasan Tahseen.
Abstract (Originalsprache)
Background and Objectives: ECG, ST segment elevation may or may not be observed in patients experiencing ischemia pain. Most patients who have ST-segment elevation go on to have a Q-wave AMI (QMI). Patients who do not exhibit ST-segment elevation are either suffering from non-ST segment elevation MI (NSTEMI) or unstable angina (UA). When the myocardium's blood flow and oxygen demand are out of balance, acute coronary insufficiency occurs. When blood flow stops, there are significant ultra-structural alterations that impact the circulating albumin protein. Serum albumin measurement may be useful in the treatment of individuals admitted to the hospital with suspected ACS. The purpose of this study was to analyze the differences between NSTEMI, STMI, and UA patients and investigate different blood albumin level follow-up measurements in ACS patients. Patients and Method: Patients admitted to the critical care unit (CCU) at AL Kadhmia Teaching Hospital between April 2022 and 2024 were the subjects of this study. There are 200 ACS patients in total (138 AMI and 62 UA). The results of the clinical examination, ECG, echo, CXR, lipid profile, and cardiac enzyme were used by the cardiologist to make the diagnosis.
Results
In this study, 200 ACS patients take part. In order to compare non-ST elevation AMI, ST elevation AMI, and UA elevation, three serial blood albumin levels were measured at baseline upon hospital admission prior to 12 hours of symptom onset, peak levels at 3 days, and follow-up levels at 5 days. As controls, the outcomes were contrasted with those of healthy groups. The findings revealed that serum albumin levels in QMI and NQMI patients decreased significantly on days 1 and 3, reaching their peak value on day 3 after the infarction. On the other hand, patients exhibited recovery on day 5 as the inflammatory response subsided, whereas patients with UA experienced a non-significant drop in serum albumin levels on days 1 and 3 following the attack.
Conclusion
It has been shown that serum albumin serves as a signal for assessing the prognosis of serious illnesses. The evidence points to the independent involvement of inflammatory processes in the pathophysiology of myocardial infarction.
Zitieren
APA
Tahseen, Y. H. (2025). Evaluation of Serum Albumin Level in Patients with Acute Coronary Syndrome. IFR Journal of Medical Science and Case Report, 1(2), 7-11. https://doi.org/10.70146/mscrv01i02.002
Vancouver
Tahseen YH. Evaluation of Serum Albumin Level in Patients with Acute Coronary Syndrome. IFR Journal of Medical Science and Case Report. 2025;1(2):7-11. doi:10.70146/mscrv01i02.002
BibTeX
@article{Tahseen2025,
author = {Tahseen, Yildiz Hasan},
title = {Evaluation of Serum Albumin Level in Patients with Acute Coronary Syndrome},
journal = {IFR Journal of Medical Science and Case Report},
year = {2025},
volume = {1},
number = {2},
pages = {7--11},
doi = {10.70146/mscrv01i02.002}
}
EUVIMED